Published in Hepatitis Weekly, February 5th, 1996
Chronic hepatitis C virus (HCV) infection is highly prevalent in hemophilic patients treated in the past with non-virally inactivated clotting factor concentrates. While the long-term consequences of this infection are not yet known, information available from non-hemophilic patients indicates that a substantial proportion will progress to cirrhosis over the course of two or more decades, with the clinical sequelae of hepatic decompensation, variceal bleeding, and hepatocellular...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.